Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Efficient preparation of human and mouse CD1d proteins using silkworm baculovirus expression system.

Kusaka H, Kita S, Tadokoro T, Yoshida K, Kasai Y, Niiyama H, Fujimoto Y, Hanashima S, Murata M, Sugiyama S, Ose T, Kuroki K, Maenaka K.

Protein Expr Purif. 2020 Mar 22:105631. doi: 10.1016/j.pep.2020.105631. [Epub ahead of print]

PMID:
32213313
2.

Increased arterial velocity pulse index is an independent factor related to skeletal muscle mass reduction and tissue damage in patients with cardiovascular disease.

Harada H, Ikeda H, Nishiyama Y, Niiyama H, Katoh A, Kai H.

Hypertens Res. 2020 Feb 5. doi: 10.1038/s41440-020-0404-6. [Epub ahead of print]

PMID:
32024966
3.

Low blood pressure and cardiovascular events in diabetic patients with coronary artery disease after revascularization: the CREDO-Kyoto registry cohort-1.

Kai H, Katoh A, Harada H, Niiyama H, Furukawa Y, Kimura T; CREDO-Kyoto Investigators.

Hypertens Res. 2020 Feb 4. doi: 10.1038/s41440-020-0407-3. [Epub ahead of print]

PMID:
32015482
4.

Oral Administration of Glucosamine Improves Vascular Endothelial Function by Modulating Intracellular Redox State.

Katoh A, Kai H, Harada H, Niiyama H, Ikeda H.

Int Heart J. 2017 Dec 12;58(6):926-932. doi: 10.1536/ihj.16-534. Epub 2017 Nov 17.

5.

New diagnostic index for sarcopenia in patients with cardiovascular diseases.

Harada H, Kai H, Shibata R, Niiyama H, Nishiyama Y, Murohara T, Yoshida N, Katoh A, Ikeda H.

PLoS One. 2017 May 18;12(5):e0178123. doi: 10.1371/journal.pone.0178123. eCollection 2017.

6.

Effectiveness of Cardiac Rehabilitation for Prevention and Treatment of Sarcopenia in Patients with Cardiovascular Disease - A Retrospective Cross-Sectional Analysis.

Harada H, Kai H, Niiyama H, Nishiyama Y, Katoh A, Yoshida N, Fukumoto Y, Ikeda H.

J Nutr Health Aging. 2017;21(4):449-456. doi: 10.1007/s12603-016-0743-9.

PMID:
28346572
7.

Effect of Exercise Training on Red Blood Cell Distribution Width as a Marker of Impaired Exercise Tolerance in Patients With Coronary Artery Disease.

Nishiyama Y, Niiyama H, Harada H, Katou A, Yoshida N, Ikeda H.

Int Heart J. 2016 Sep 28;57(5):553-7. doi: 10.1536/ihj.16-015. Epub 2016 Sep 1.

8.

Demonstration of the disease activity by serial carotid artery ultrasonography, magnetic resonance imaging and 18-fluoro-deoxyglucose positron emission tomography in a Beh├žet's disease patient with carotid artery stenosis.

Igata S, Tahara N, Tahara A, Honda A, Nitta Y, Kusaba K, Niiyama H, Kaida H, Abe T, Yoshiyama H, Fukumoto Y.

Eur Heart J. 2015 Jul 1;36(25):1629. doi: 10.1093/eurheartj/ehv031. Epub 2015 Feb 24. No abstract available.

PMID:
25713315
9.

Laronidase replacement therapy and left ventricular function in mucopolysaccharidosis I.

Harada H, Niiyama H, Katoh A, Ikeda H.

JIMD Rep. 2014;16:39-45. doi: 10.1007/8904_2014_316. Epub 2014 May 22.

10.

Systolic blood pressure during recovery from exercise is related to flow-mediated dilatation in patients with coronary artery disease.

Nishiyama Y, Sakaue A, Matsuo S, Niiyama H, Harada H, Katoh A, Ikeda H.

Heart Asia. 2014 Jun 13;6(1):83-6. doi: 10.1136/heartasia-2013-010457. eCollection 2014.

11.

Development of novel wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor and vitamin C derivative.

Niiyama H, Kuroyanagi Y.

J Artif Organs. 2014 Mar;17(1):81-7. doi: 10.1007/s10047-013-0737-x. Epub 2013 Dec 1.

PMID:
24292853
12.

Wound dressing composed of hyaluronic acid and collagen containing EGF or bFGF: comparative culture study.

Yu A, Niiyama H, Kondo S, Yamamoto A, Suzuki R, Kuroyanagi Y.

J Biomater Sci Polym Ed. 2013;24(8):1015-26. doi: 10.1080/09205063.2012.731375. Epub 2012 Nov 26.

PMID:
23647255
13.

Stent-anchored coil embolotherapy--novel treatment procedure for huge pulmonary arterio-venous malformation in hereditary hemorrhagic telangiectasia.

Koiwaya H, Kai H, Ueno T, Niiyama H, Takeuchi T, Ueda S, Gondo T, Kumagai E, Miyamoto M, Yokoyama S, Sasaki K, Toyama Y, Ohtsuka M, Mitsutake Y, Anegawa T, Nakayoshi T, Kudo Y, Suda K, Imaizumi T.

Int J Cardiol. 2012 May 17;157(1):122-4. doi: 10.1016/j.ijcard.2012.03.049. Epub 2012 Mar 27. No abstract available.

PMID:
22459369
14.

Longest survivor of pulmonary atresia with ventricular septal defect: well-developed major aortopulmonary collateral arteries demonstrated by multidetector computed tomography.

Fukui D, Kai H, Takeuchi T, Gondo T, Oba T, Mawatari K, Tonai T, Matsuo Y, Ueda S, Niiyama H, Ueno T, Imaizumi T.

Circulation. 2011 Nov 8;124(19):2155-7. doi: 10.1161/CIRCULATIONAHA.111.035469. No abstract available.

PMID:
22064959
15.

Clinical usefulness of a high-concentration calcium chloride solution method to correct the activated partial thromboplastin time in a high hematocrit model with heparin therapy.

Kanahara M, Harada H, Niiyama H, Katoh A, Kai H, Ikeda H.

Thromb Res. 2012 Feb;129(2):215-7. doi: 10.1016/j.thromres.2011.08.026. Epub 2011 Sep 23. No abstract available.

PMID:
21943813
16.

Evaluation of a wound dressing composed of hyaluronic acid and collagen sponge containing epidermal growth factor in diabetic mice.

Kondo S, Niiyama H, Yu A, Kuroyanagi Y.

J Biomater Sci Polym Ed. 2012;23(13):1729-40. doi: 10.1163/092050611X597799. Epub 2012 May 8.

PMID:
21943516
17.

Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion.

Huang NF, Niiyama H, Peter C, De A, Natkunam Y, Fleissner F, Li Z, Rollins MD, Wu JC, Gambhir SS, Cooke JP.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):984-91. doi: 10.1161/ATVBAHA.110.202796. Epub 2010 Feb 18.

18.

Conjugal transformation and transposon and chemical mutagenesis of gram-negative selenate-respiring Citrobacter sp. strain JSA.

Sakaguchi T, Kato M, Kuriyama N, Niiyama H, Hamada S, Morita Y, Tamiya E.

Curr Microbiol. 2009 Jul;59(1):88-94. doi: 10.1007/s00284-009-9406-y. Epub 2009 Apr 14.

PMID:
19365687
19.

Embryonic stem cell-derived endothelial cells for treatment of hindlimb ischemia.

Huang NF, Niiyama H, De A, Gambhir SS, Cooke JP.

J Vis Exp. 2009 Jan 23;(23). pii: 1034. doi: 10.3791/1034.

20.

Murine model of hindlimb ischemia.

Niiyama H, Huang NF, Rollins MD, Cooke JP.

J Vis Exp. 2009 Jan 21;(23). pii: 1035. doi: 10.3791/1035.

21.

Animal-assisted activity: experiences of institutionalized Japanese older adults.

Kawamura N, Niiyama M, Niiyama H.

J Psychosoc Nurs Ment Health Serv. 2009 Jan;47(1):41-7.

PMID:
19227109
22.

A novel safe approach to the peritoneal cavity for per-oral transgastric endoscopic procedures.

Kantsevoy SV, Jagannath SB, Niiyama H, Isakovich NV, Chung SS, Cotton PB, Gostout CJ, Hawes RH, Pasricha PJ, Kalloo AN.

Gastrointest Endosc. 2007 Mar;65(3):497-500.

PMID:
17321254
23.

The endoscopic transilluminator: an endoscopic device for identification of the proximal jejunum for transgastric endoscopic gastrojejunostomy.

Kantsevoy SV, Niiyama H, Jagannath SB, Chung SS, Cotton PB, Gostout CJ, Hawes RH, Pasricha PJ, Magee CA, Vaughn CA, Barlow D, Kawano H, Shimonaka H, Kalloo AN.

Gastrointest Endosc. 2006 Jun;63(7):1055-8.

PMID:
16733125
24.

Oddi's sphincter dysfunction.

Niiyama H, Kalloo AN.

Minerva Gastroenterol Dietol. 2003 Mar;49(1):31-40.

PMID:
16481969
25.

Endoscopic gastrojejunostomy with survival in a porcine model.

Kantsevoy SV, Jagannath SB, Niiyama H, Chung SS, Cotton PB, Gostout CJ, Hawes RH, Pasricha PJ, Magee CA, Vaughn CA, Barlow D, Shimonaka H, Kalloo AN.

Gastrointest Endosc. 2005 Aug;62(2):287-92.

PMID:
16046997
26.

Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats.

Tahara N, Kai H, Niiyama H, Mori T, Sugi Y, Takayama N, Yasukawa H, Numaguchi Y, Matsui H, Okumura K, Imaizumi T.

Hum Gene Ther. 2004 Dec;15(12):1270-8.

PMID:
15684702
27.

Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization.

Niiyama H, Kai H, Yamamoto T, Shimada T, Sasaki K, Murohara T, Egashira K, Imaizumi T.

J Am Coll Cardiol. 2004 Aug 4;44(3):661-6.

28.

Flexible transgastric peritoneoscopy: a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity.

Kalloo AN, Singh VK, Jagannath SB, Niiyama H, Hill SL, Vaughn CA, Magee CA, Kantsevoy SV.

Gastrointest Endosc. 2004 Jul;60(1):114-7.

PMID:
15229442
29.

Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis.

Shibata R, Kai H, Seki Y, Kusaba K, Takemiya K, Koga M, Jalalidin A, Tokuda K, Tahara N, Niiyama H, Nagata T, Kuwahara F, Imaizumi T.

J Cardiovasc Pharmacol. 2003 Dec;42 Suppl 1:S43-7.

PMID:
14871028
30.

Intrasphincteric nitric oxide reduces sphincter of Oddi motility in an endoscopic porcine model.

Niiyama H, Jagannath S, Kantsevoy S, Cruz-Correa M, Magee C, Kalloo AN.

Dig Dis Sci. 2003 Nov;48(11):2187-90.

PMID:
14705826
31.

Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling.

Kuwahara F, Kai H, Tokuda K, Niiyama H, Tahara N, Kusaba K, Takemiya K, Jalalidin A, Koga M, Nagata T, Shibata R, Imaizumi T.

Hypertension. 2003 Mar;41(3 Pt 2):819-23. Epub 2003 Feb 3.

PMID:
12624002
32.

Cloning of cDNA for UDP-glucose pyrophosphorylase and the expression of mRNA in rice endosperm.

Abe T, Niiyama H, Sasahara T.

Theor Appl Genet. 2002 Aug;105(2-3):216-221. Epub 2002 Jun 7.

PMID:
12582522
33.

Coexistence of hypercholesterolemia and hypertension impairs adventitial vascularization.

Kai H, Kuwahara F, Tokuda K, Shibata R, Kusaba K, Niiyama H, Tahara N, Nagata T, Imaizumi T.

Hypertension. 2002 Feb;39(2 Pt 2):455-9.

PMID:
11882589
34.

Hypoxia-inducible factor-1alpha/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta.

Kuwahara F, Kai H, Tokuda K, Shibata R, Kusaba K, Tahara N, Niiyama H, Nagata T, Imaizumi T.

Hypertension. 2002 Jan;39(1):46-50.

PMID:
11799077
35.

Carcinoma arising in choledochocele.

Ohtsuka T, Inoue K, Ohuchida J, Nabae T, Takahata S, Niiyama H, Yokohata K, Ogawa Y, Yamaguchi K, Chijiiwa K, Tanaka M.

Endoscopy. 2001 Jul;33(7):614-9.

PMID:
11473335
36.

Quantitative analysis of hTERT mRNA expression in colorectal cancer.

Niiyama H, Mizumoto K, Sato N, Nagai E, Mibu R, Fukui T, Kinoshita M, Tanaka M.

Am J Gastroenterol. 2001 Jun;96(6):1895-900.

PMID:
11419845
37.

Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis.

Mizumoto I, Ogawa Y, Niiyama H, Nagai E, Sato I, Urashima T, Matsumoto T, Iida M, Tanaka I.

Am J Gastroenterol. 2001 Apr;96(4):1261-5.

PMID:
11316180
38.

Diverse effects of 9-hydroxyellipticine on the chemosensitivity of human pancreatic cancer cells harboring p53 mutations.

Mizumoto K, Sato N, Kusumoto M, Niiyama H, Maehara N, Nishio S, Li Z, Ogawa T, Tanaka M.

Cancer Lett. 2000 Feb 28;149(1-2):85-94.

PMID:
10737712
39.

Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells.

Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N, Nakamura M, Tanaka M.

Clin Cancer Res. 1999 Aug;5(8):2140-7.

40.

Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin.

Zhang L, Mizumoto K, Sato N, Ogawa T, Kusumoto M, Niiyama H, Tanaka M.

Cancer Lett. 1999 Aug 3;142(2):129-37.

PMID:
10463768
41.

Stricture of the main pancreatic duct due to focal pancreatitis coexistent with pancreatic cystadenoma.

Mizumoto K, Ogawa T, Koike E, Niiyama H, Yokohata K, Sumii T, Yonemasu H, Tanaka M.

Pancreas. 1999 Aug;19(2):211-3. No abstract available.

PMID:
10438172
42.

Centrosome abnormalities in pancreatic ductal carcinoma.

Sato N, Mizumoto K, Nakamura M, Nakamura K, Kusumoto M, Niiyama H, Ogawa T, Tanaka M.

Clin Cancer Res. 1999 May;5(5):963-70.

43.

Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms.

Niiyama H, Mizumoto K, Kusumoto M, Ogawa T, Suehara N, Shimura H, Tanaka M.

Cancer. 1999 May 15;85(10):2138-43.

PMID:
10326691
44.

9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.

Sato N, Mizumoto K, Kusumoto M, Niiyama H, Maehara N, Ogawa T, Tanaka M.

FEBS Lett. 1998 Dec 18;441(2):318-21.

45.

Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.

Suehara N, Mizumoto K, Tanaka M, Niiyama H, Yokohata K, Tominaga Y, Shimura H, Muta T, Hamasaki N.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2479-83.

46.

Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.

Suehara N, Mizumoto K, Kusumoto M, Niiyama H, Ogawa T, Yamaguchi K, Yokohata K, Tanaka M.

Am J Gastroenterol. 1998 Oct;93(10):1967-71.

PMID:
9772067
47.

Pancreatic carcinoma in remnant pancreas after pancreatectomy for mucinous cystadenoma.

Niiyama H, Yamaguchi K, Shimizu S, Yokohata K, Chijiiwa K, Yonemasu H, Tanaka M.

Eur J Gastroenterol Hepatol. 1998 Aug;10(8):703-7.

PMID:
9744701
48.

[Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice].

Suehara N, Mizumoto K, Niiyama H, Tanaka M.

Nihon Rinsho. 1998 May;56(5):1223-8. Review. Japanese.

PMID:
9613127
49.
50.

Intersegmental connection with aberrant hepatic duct.

Niiyama H, Yoshida J, Kuroki N, Maeda Y, Nagata T.

Abdom Imaging. 1994 Sep-Oct;19(5):425-6.

PMID:
7950818

Supplemental Content

Loading ...
Support Center